Muhammad Mamdani

MPH, MA, PharmD

Director, Li Ka Shing Centre for Healthcare Analytics Research and Training (CHART)


Dr. Mamdani is the Director of the Li Ka Shing Centre for Healthcare Analytics Research and Training (CHART) of the Li Ka Shing Knowledge Institute of St. Michael’s Hospital in Toronto. He is also Professor in the Leslie Dan Faculty of Pharmacy, the Department of Medicine of the Faculty of Medicine, and the Institute of Health Policy, Management and Evaluation of the Dalla Lana Faculty of Public Health. He is also adjunct Senior Scientist at the Institute for Clinical Evaluative Sciences (ICES). Dr. Mamdani also is a member of the Human Drug Advisory Panel of the Patented Medicine Prices Review Board (PMPRB) and is a co-Principal Investigator of the Ontario Drug Policy Research Network. In 2010, Dr. Mamdani was named among Canada’s Top 40 under 40. Prior to joining the Li Ka Shing Knowledge Institute and St. Michael’s Hospital, Dr. Mamdani was a Director of Outcomes Research at Pfizer Global Pharmaceuticals in New York. Dr. Mamdani’s research interests include pharmacoepidemiology, pharmacoeconomics, and drug policy. He has published approximately 350 research studies in peer-reviewed medical journals, including leading journals such as the New England Journal of Medicine, the Lancet, the Journal of the American Medical Association, the British Medical Journal, and Annals of Internal Medicine.

Dr. Mamdani obtained a Doctor of Pharmacy degree (PharmD) from the University of Michigan (Ann Arbor) in 1995 and subsequently completed a fellowship in pharmacoeconomics and outcomes research at the Detroit Medical Center in 1997. During his fellowship, Dr. Mamdani obtained a Master of Arts degree in Economics from Wayne State University in Detroit, Michigan. He then completed a Master of Public Health degree from Harvard University in 1998 with a concentration in quantitative methods, focusing on biostatistics and epidemiological principles.

Please note: Dr. Mamdani is not taking any summer students in 2018.




Recent Publications

  1. Martins, D, Khuu, W, Tadrous, M, Juurlink, DN, Mamdani, MM, Paterson, JM et al.. Impact of delisting high-strength opioid formulations from a public drug benefit formulary on opioid utilization in Ontario, Canada. Pharmacoepidemiol Drug Saf. 2019; :. doi: 10.1002/pds.4764. PubMed PMID:30873707 .
  2. Morrow, RL, Dormuth, CR, Paterson, M, Mamdani, MM, Gomes, T, Juurlink, DN et al.. Tramadol and the risk of seizure: nested case-control study of US patients with employer-sponsored health benefits. BMJ Open. 2019;9 (3):e026705. doi: 10.1136/bmjopen-2018-026705. PubMed PMID:30872555 .
  3. Gupta, S, Price, C, Agarwal, G, Chan, D, Goel, S, Boulet, LP et al.. The Electronic Asthma Management System (eAMS) Improves Primary Care Asthma Management. Eur. Respir. J. 2019; :. doi: 10.1183/13993003.02241-2018. PubMed PMID:30765503 .
  4. Tadrous, M, Greaves, S, Martins, D, Nadeem, K, Singh, S, Mamdani, MM et al.. Evaluation of the fentanyl patch-for-patch program in Ontario, Canada. Int. J. Drug Policy. 2019;66 :82-86. doi: 10.1016/j.drugpo.2019.01.025. PubMed PMID:30743092 .
  5. Rajaram, A, Morey, T, Dosani, N, Pou-Prom, C, Mamdani, M. Palliative Care in the Twenty-First Century: Using Advanced Analytics to Uncloak Insights from Big Data. J Palliat Med. 2019;22 (2):124-125. doi: 10.1089/jpm.2018.0609. PubMed PMID:30707078 .
  6. Price, C, Agarwal, G, Chan, D, Goel, S, Kaplan, AG, Boulet, LP et al.. Large care gaps in primary care management of asthma: a longitudinal practice audit. BMJ Open. 2019;9 (1):e022506. doi: 10.1136/bmjopen-2018-022506. PubMed PMID:30696669 PubMed Central PMC6352804.
  7. Salata, K, Hussain, MA, de Mestral, C, Greco, E, Mamdani, M, Forbes, TL et al.. Prevalence of Elective and Ruptured Abdominal Aortic Aneurysm Repairs by Age and Sex From 2003 to 2016 in Ontario, Canada. JAMA Netw Open. 2018;1 (7):e185418. doi: 10.1001/jamanetworkopen.2018.5418. PubMed PMID:30646400 PubMed Central PMC6324588.
  8. Gomes, T, Tadrous, M, Mamdani, MM, Paterson, JM, Juurlink, DN. The Burden of Opioid-Related Mortality in the United States. JAMA Netw Open. 2018;1 (2):e180217. doi: 10.1001/jamanetworkopen.2018.0217. PubMed PMID:30646062 PubMed Central PMC6324425.
  9. Jayasundara, K, Hollis, A, Krahn, M, Mamdani, M, Hoch, JS, Grootendorst, P et al.. Estimating the clinical cost of drug development for orphan versus non-orphan drugs. Orphanet J Rare Dis. 2019;14 (1):12. doi: 10.1186/s13023-018-0990-4. PubMed PMID:30630499 PubMed Central PMC6327525.
  10. Xu, Y, Gomes, T, Mamdani, MM, Juurlink, DN, Cadarette, SM, Tadrous, M et al.. Analysis of Trends in Insulin Utilization and Spending Across Canada From 2010 to 2015. Can J Diabetes. 2018; :. doi: 10.1016/j.jcjd.2018.08.190. PubMed PMID:30545737 .
Search PubMed

Affiliations & Other Activities

  • Scientist, Li Ka Shing Knowledge Institute, St. Michael’s Hospital
  • Professor, Institute of Health Policy, Management, and Evaluation, University of Toronto
  • Professor, Leslie Dan Faculty of Pharmacy, University of Toronto
  • Adjunct Professor, King Saud University Senior Adjunct
  • Scientist, Institute for Clinical Evaluative Sciences